West Pharma adds Dr. Stephen Lockhart as director; $90K retainer + $190K RSU

WEST PHARMACEUTICAL SERVICES INC

Elected July 26, 2022; Board expands to 11 members.
Dr. Lockhart, former CMO of Sutter Health, appointed to Innovation & Technology and Finance Committees.
Receives prorated $90,000 annual cash retainer and $190,000 annual RSU grant (grant date Aug 1, 2022).
Also eligible for Director Deferred Compensation Plan and standard indemnification agreement.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Lockhart

Director

WST · WEST PHARMACEUTICAL SERVICES INC

Effective: 2022-07-26
Filed: July 27, 2022, 7:59 PM ET

On July 26, 2022, West Pharmaceutical Services, Inc. (the "Company") elected Stephen Lockhart, M.D., Ph.D., to its Board of Directors (the "Board") as its newest member.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Lockhart was elected as Director at WEST PHARMACEUTICAL SERVICES INC.

Action: elected
Role: Director

Exact text from the filing

On July 26, 2022, West Pharmaceutical Services, Inc. (the "Company") elected Stephen Lockhart, M.D., Ph.D., to its Board of Directors (the "Board") as its newest member.

View on SEC.gov

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-22-000038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.